ReShape Lifesciences IncEigentümerstruktur
| Preis (2025-08-14) | 52W Hoch | 52W Tief |
| 15.68 USD | 18,6 USD | 7,48 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 1 USD | 0 | 0 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 2.385.960 | 2,19 | 0,48 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name ReShape Lifesciences Inc
Mitarbeiter 17
Handelsplatz NASDAQ
Ticker Symbol RSLS
IPO Datum 2007-11-15
Adresse 18 Technology Drive, Irvine, CA, United States, 92618
Webseite https://www.reshapelifesciences.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Dan W. Gladney | Executive Chair |
| 2 | Mr. Paul F. Hickey | CEO, President & Director |
| 3 | Mr. Thomas Stankovich | Senior VP & CFO |
| 4 | Mr. Al Diaz | Vice President of Operations and R&D |
| 5 | Dr. Dov Gal D.V.M., M.B.A. | VP of Regulatory Clinical Quality & Compliance Officer |
| 6 | Mr. Naqeeb A. Ansari | Senior Vice President of Global Commercial Operations |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 2 | Tower Research Capital LLC | 0,00% | 0,00 Mio. USD |
| 3 | Atlantic Trust Group, LLC | 0,00% | 0,00 Mio. USD |
| 4 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 5 | SBI Securities Co Ltd | 0,00% | 0,00 Mio. USD |